Treatment adenocarcinoma cardia synchronous chemotherapy radiotherapy Twenty-nine evaluable patients adenocarcinoma cardia chemotherapy cycles cisplatin Gy radiation tumours responsive treatment Complete regression tumour patients partial regression Fourteen patients tumours microscopic tumour specimen Nine patients additional radiotherapy total dose Gy surgery response rapid reversal dysphagia patient subsequent intervention relief dysphagia due fibrous stricture Enhanced survival complete endoscopic response initial chemotherapy radiotherapy tumour cm length median survival patients months Synchronous chemotherapy radiotherapy major palliative benefit series merits evaluation 